T-cell proliferation and forkhead box P3 expression in human T cells are dependent on T-cell density: Physics of a confined space?

Human Immunology

Volumn 73, Issue 3, 2012, Pages 223-231

  Bernardo, David ^a   Al Hassi, Hafid O ^a   Mann, Elizabeth R ^a   Tee, Cheng T ^a   Murugananthan, Aravinth U ^a   Peake, Simon T C ^a   Hart, Ailsa L ^b   Knight, Stella C ^a  

^a IMPERIAL COLLEGE LONDON   (United Kingdom)

^b ST MARK S HOSPITAL   (United Kingdom)

Author keywords

Cell density; FoxP3; Human; Proliferation rate; Regulatory T cells

Indexed keywords

CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 17; TRANSCRIPTION FACTOR FOXP3; TRANSCRIPTION FACTOR T BET; TRANSFORMING GROWTH FACTOR BETA;

ANTIGEN PRESENTING CELL; ARTICLE; CELL DENSITY; CELL DIVISION; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; T LYMPHOCYTE;

ANTIGEN-PRESENTING CELLS; CELL COUNT; CELL DIFFERENTIATION; CELL PROLIFERATION; CELLS, CULTURED; CELLULAR MICROENVIRONMENT; COCULTURE TECHNIQUES; FORKHEAD TRANSCRIPTION FACTORS; GENE EXPRESSION REGULATION; HUMANS; IMMUNE TOLERANCE; LYMPHOCYTE ACTIVATION; T-BOX DOMAIN PROTEINS; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, REGULATORY;

EID: 84857108480     PISSN: 01988859     EISSN: 18791166     Source Type: Journal    
DOI: 10.1016/j.humimm.2011.12.017     Document Type: Article

References (38)

1. + Tregs and NKT cells: regulators regulating regulators. Trends Immunol 2006, 27:322-327.
2. Vignali D.A., Collison L.W., Workman C.J. How regulatory T cells work. Nat Rev Immunol 2008, 8:523-532.
3. Fontenot J.D., Rudensky A.Y. A well adapted regulatory contrivance: regulatory T cell development and the forkhead family transcription factor Foxp3. Nat Immunol 2005, 6:331-337.
4. Iliev I.D., Mileti E., Matteoli G., Chieppa M., Rescigno M. Intestinal epithelial cells promote colitis-protective regulatory T-cell differentiation through dendritic cell conditioning. Mucosal Immunol 2009, 2:340-350.
5. + dendritic cells express indoleamine 2,3-dioxygenase which influences T regulatory/T effector cell balance and oral tolerance induction. Gut 2010, 59:595-604.
6. Murai M., Krause P., Cheroutre H., Kronenberg M. Regulatory T-cell stability and plasticity in mucosal and systemic immune systems. Mucosal Immunol 2010, 3:443-449.
7. Allan S.E., Crome S.Q., Crellin N.K., Passerini L., Steiner T.S., Bacchetta R., et al. Activation-induced FOXP3 in human T effector cells does not suppress proliferation or cytokine production. Int Immunol 2007, 19:345-354.
8. Pillai V., Ortega S.B., Wang C.K., Karandikar N.J. Transient regulatory T-cells: a state attained by all activated human T-cells. Clin Immunol 2007, 123:18-29.
9. + suppressor T cells. Immunol Rev 2011, 182:58-67.
10. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998, 188:287-296.
11. + T cells. Nat Immunol 2007, 8:1353-1362.
12. Farrant J., Knight S.C. Help and suppression by lymphoid cells as a function of cellular concentration. Proc Natl Acad Sci U S A 1979, 76:3507-3510.
13. Knight S.C. Control of lymphocyte stimulation in vitro: "help" and "suppression" in the light of lymphoid population dynamics. J Immunol Methods 1982, 50:R51-R63.
14. Thorpe P.E., Knight S.C. Microplate culture of mouse lymph node cells. I. Quantitation of responses to allogeneic lymphocytes endotoxin and phytomitogens. J Immunol Methods 1974, 5:387-404.
15. Knight S.C., Farrant J., Bryant A., Edwards A.J., Burman S., Lever A., et al. Non-adherent, low-density cells from human peripheral blood contain dendritic cells and monocytes, both with veiled morphology. Immunology 1986, 57:595-603.
16. +) colonic lamina propria cells is associated with inflammation in ulcerative colitis. Clin Exp Immunol 2009, 158:205-218.
17. Bagwell C.B. Hyperlog-a flexible log-like transform for negative, zero, and positive valued data. Cytometry 2005, 64:34-42.
18. Pillai V., Karandikar N.J. Attack on the clones?. Human FOXP3 detection by PCH101, 236A/E7, 206D, and 259D reveals 259D as the outlier with lower sensitivity. Blood 2008, 111:463-464.
19. Duarte J.H., Zelenay S., Bergman M.L., Martins A.C., Demengeot J. Natural Treg cells spontaneously differentiate into pathogenic helper cells in lymphopenic conditions. Eur J Immunol 2009, 39:948-955.
20. Gavin M.A., Rasmussen J.P., Fontenot J.D., Vasta V., Manganiello V.C., Beavo J.A., et al. Foxp3-dependent programme of regulatory T-cell differentiation. Nature 2007, 445:771-775.
21. Kastner L., Dwyer D., Qin F.X. Synergistic effect of IL-6 and IL-4 in driving fate revision of natural Foxp3+ regulatory T cells. J Immunol 2010, 185:5778-5786.
22. Xu L., Kitani A., Strober W. Molecular mechanisms regulating TGF-beta-induced Foxp3 expression. Mucosal Immunol 2010, 3:230-238.
23. Oldenhove G., Bouladoux N., Wohlfert E.A., Hall J.A., Chou D., Dos Santos L., et al. Decrease of Foxp3+ Treg cell number and acquisition of effector cell phenotype during lethal infection. Immunity 2009, 31:772-786.
24. Schadenberg A.W., Vastert S.J., Evens F.C., Kuis W., van Vught A.J., Jansen N.J., et al. FOXP3(+) CD4(+) Tregs lose suppressive potential but remain anergic during transient inflammation in human. Eur J Immunol 2011, 41:1132-1142.
25. Wohlfert E., Belkaid Y. Plasticity of T reg at infected sites. Mucosal Immunol 2010, 3:213-215.
26. Zhou X., Bailey-Bucktrout S.L., Jeker L.T., Penaranda C., Martínez-Llordella M., Ashby M., et al. Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. Nat Immunol 2009, 10:1000-1007.
27. Gibbons D.L., Spencer J. Mouse and human intestinal immunity: same ballpark, different players; different rules, same score. Mucosal Immunol 2011, 4:148-157.
28. Gavin M.A., Torgerson T.R., Houston E., DeRoos P., Ho W.Y., Stray-Pedersen A., et al. Single-cell analysis of normal and FOXP3-mutant human T cells: FOXP3 expression without regulatory T cell development. Proc Natl Acad Sci U S A 2006, 103:6659-6664.
29. Miyara M., Sakaguchi S. Human FoxP3(+)CD4(+) regulatory T cells: their knowns and unknowns. Immunol Cell Biol 2011, 89:346-351.
30. + T regulatory cells in humans. Hum Immunol 2005, 66:13-20.
31. Prado C., Gómez J., López P., de Paz B., Gutiérrez C., Suárez A. Dexamethasone upregulates FOXP3 expression without increasing regulatory activity. Immunobiology 2011, 216:386-392.
32. Roncarolo M.G., Gregori S. Is FOXP3 a bona fide marker for human regulatory T cells?. Eur J Immunol 2008, 38:925-927.
33. +FOXP3 T cells by T-cell receptor stimulation is transforming growth factor-beta dependent but does not confer a regulatory phenotype. Blood 2007, 110:2983-2990.
34. + T cells. Eur J Immunol 2007, 37:129-138.
35. Sakaguchi S., Miyara M., Costantino C.M., Hafler D.A. FOXP3+ regulatory T cells in the human immune system. Nat Rev Immunol 2010, 10:490-500.
36. Dige A., Hvas C.L., Kelsen J., Deleuran B., Dahlerup J.F., Agnholt J. Ethylene-diamine-tetra-acetate (EDTA) mimics the effect of regulatory T cells in suppression assays: a potential pitfall when using AutoMACS-separated cells. J Immunol Methods 2010, 353:141-144.
37. Sadlon T.J., Wilkinson B.G., Pederson S., Brown C.Y., Bresatz S., Gargett T., et al. Genome-wide identification of human FOXP3 target genes in natural regulatory T cells. J Immunol 2010, 185:1071-1081.
38. Tran D.Q., Glass D.D., Uzel G., Darnell D.A., Spalding C., Holland S.M., et al. Analysis of adhesion molecules, target cells, and role of IL-2 in human FOXP3+ regulatory T cell suppressor function. J Immunol 2009, 182:2929-2938.